Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions

Raynaud Phenomenon Due to TraumaRaynaud DiseaseSystem; SclerosisLupus Erythematosus, SystemicDermatomyositisUltrasound Therapy; Complications

Interventions

DRUG

10% nifedipine cream

Topical treatment for Raynaud

DRUG

5% sildenafil cream

Topical treatment for Raynaud

Trial Locations (1)

Department of Dermatology, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile., Santiago

All Listed Sponsors

lead

Pontificia Universidad Catolica de Chile

OTHER

NCT03027674 - Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud | Biotech Hunter | Biotech Hunter